ION, an Interventional Orthopedic Network

 

Our Mission

To offer workers compensation payers and injured workers the most advanced non-surgical orthopedic care in the United States. We have partnered with Regenexx to leverage their patented, regenerative treatments within the specialty area of Interventional Orthopedics.


What is Interventional Orthopedics?

The traditional continuum of orthopedic care follows the course of pharmaceuticals to physical therapy and inevitably surgery. Interventional Orthopedics ‘intervenes’ this path giving a patient an alternative to surgery. These advanced treatments prevent the need for invasive orthopedic surgeries by using a patient’s own orthobiologics to heal themselves by way of outpatient, minimally invasive, image guided injections. Orthobiologics are natural biological substances within the body (blood platelets, stem cells and cytokines) that facilitate healing of musculoskeletal structures such as cartilage, bone, ligaments and tendons.

What are the benefits?

Payers who leverage these procedures see on average a greater than 70% reduction in orthopedic surgical spending. Importantly, when given an alternative to surgery, injured workers choose this option more than 99% of the time. These procedures benefit both payer and patient by avoiding costly and risky surgery:

Payer   

- 70%+ reduction in orthopedic cost  

- Over 95% avoid surgery  

- Faster return to work 

- Less physical therapy / pain medication 

Patient

- Better outcomes than surgery

- Significantly less risk than surgery

- Faster recovery

- Less invasive and painful than surgery

Why Regenexx?

Regenerative medicine is one of the fastest growing medical fields in the world, which also makes development and adherence to best practices, standards and regulations in this field critical to success and an important area of differentiation.  Regenexx is the leader in developing standards and protocols, and is second to none in research and outcomes-based efficacy:  

- Research Based Procedures – Regenexx has published over 44% of the world’s research in this field 

- Fully FDA Compliant (CFR 21 Part 1271) Procedures – the only network that has a court order that validates their procedure protocols as FDA Compliant 

- Outcomes Database – the only network and orthopedic enterprise that monitors the outcomes of procedures dating back to 2005 (over 100K procedures to date)

- Standardized Procedures and Protocol Quality Assurance Program – the only network with this program 

- Physician Evaluation and Education Program – the only network with an education and training program with a hands-on certification process 

- Flexible Lab Platform -  the only network that employs a flexible lab platform that provides customized dosing specific to our patented procedure protocols to treat the specific condition of each joint in the body 

- Ability to Serve Employees in all 50 States - over 60 United States clinical locations and 20 more coming in 2020. *telemedicine available for new patient evaluations for those employees outside of driving distance